BTRC Gene

📖 Wiki Page

gene1877 wordssynced 2026-04-02

BTRC (Beta-Transducin Repeat Containing Protein)

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BTRC Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>BTRC</td></tr>
<tr><td><strong>Full Name</strong></td><td>Beta-Transducin Repeat Containing Protein</td></tr>
<tr><td><strong>Alias</strong></td><td>β-TrCP, Fbxw1, Slimb</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>10q24.32</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[8945](https://www.ncbi.nlm.nih.gov/gene/8945)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[603506](https://www.omim.org/entry/603506)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000166167</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y297](https://www.uniprot.org/uniprot/Q9Y297)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td></tr>
</table>
</div>

Overview

The BTRC gene encodes β-transducin repeat-containing protein (β-TrCP), an F-box protein that serves as the substrate recognition component of the SCF (Skp1-Cullin1-F-box) E3 ubiquitin ligase complex. β-TrCP is a critical regulator of numerous cellular processes, including cell cycle progression, DNA damage responses, circadian rhythm, inflammatory signaling, and protein quality control.

...

BTRC (Beta-Transducin Repeat Containing Protein)

Overview

β-TrCP recognizes phosphorylated substrates and targets them for polyubiquitination and proteasomal degradation. Through this mechanism, β-TrCP controls the turnover of key regulatory proteins including IκBα, β-catenin, PER1/2 clock proteins, p53, and various signaling molecules. Dysregulation of β-TrCP function has been implicated in cancer, metabolic disorders, and neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.

Gene Structure and Evolution

The BTRC gene is located on chromosome 10q24.32 and encodes a protein of approximately 542 amino acids. The gene contains multiple exons and is highly conserved across eukaryotes. β-TrCP belongs to the F-box protein family, characterized by an N-terminal F-box motif that mediates interaction with Skp1, and C-terminal WD40 repeats that form a beta-propeller structure responsible for substrate recognition.

The F-box motif (approximately 40 amino acids) was first identified in yeast cyclin F (CycF) and is now known to be present in over 70 human F-box proteins. The F-box mediates binding to Skp1, which in turn connects to Cullin1, forming the core SCF complex[@winston1999]. The WD40 repeat domain (approximately 44 amino acids per repeat) forms a seven-bladed beta-propeller structure that creates a highly specific substrate-binding pocket.

β-TrCP is evolutionarily conserved from yeast to humans, with orthologs in Saccharomyces cerevisiae (Cdc4) and Drosophila melanogaster (Slimb). This conservation underscores its fundamental importance in cellular regulation. The phosphodegron recognition motif (DSGxxS) is also conserved, indicating that substrate phosphorylation-dependent ubiquitination is an ancient regulatory mechanism.

Protein Structure

β-TrCP contains an F-box domain that mediates binding to Skp1 and is essential for assembly into the SCF complex. The WD40 repeats form a beta-propeller structure responsible for substrate recognition and contain the phosphodegron-binding pocket. β-TrCP specifically recognizes substrates containing a phosphorylated degron motif (DSGxxS sequence).

Domain Architecture

F-box domain (residues 1-70): Mediates interaction with Skp1

Linker region (residues 71-120): Flexible connection between domains

WD40 repeats (residues 121-542): Seven-bladed beta-propeller for substrate recognition

Phosphodegron Recognition

The WD40 domain recognizes the phosphorylated degron with high specificity:

Recognition motif: DSGxxS or DSxGxxS (where x is any amino acid)
Phosphorylation requirement: Both serine residues must be phosphorylated
Dimerization requirement: β-TrCP functions as a dimer

Biological Functions

β-TrCP as part of the SCF complex catalyzes ubiquitination of numerous substrates including IκBα in NF-κB signaling, β-catenin in Wnt signaling, PER1/2 in circadian rhythm regulation, and p53 tumor suppressor. Through these actions, β-TrCP regulates cell cycle progression, DNA damage responses, apoptosis, inflammation, metabolism, and circadian rhythm.

Substrate Diversity

Over 40 substrates have been identified for β-TrCP, including:

NF-κB pathway: IκBα, IκBβ, NF-κB2/p100, HBV X protein
Wnt pathway: β-catenin, APC, Axin
Circadian clock: PER1, PER2, CRY1, CRY2
Cell cycle: Cdc25A, Cdc25C, Wee1
DNA damage: p53, FOXO1, BRCA1
Metabolism: SREBP, IRS-1

This remarkable substrate diversity explains β-TrCP's pleiotropic effects on cellular physiology.

Role in Alzheimer's Disease

β-TrCP influences amyloid pathology through multiple mechanisms including modulating secretase access to APP, targeting β-secretase for degradation, and influencing degradation pathways. Studies show altered β-TrCP expression in AD brains with reduced expression in affected regions and impaired substrate recognition. Through NF-κB regulation, β-TrCP modulates neuroinflammation including cytokine production, microglial activation, and chronic inflammatory responses.

Role in Parkinson's Disease

β-TrCP may influence α-synuclein clearance through regulation of autophagy pathways and interaction with degradation systems. MPTP models show β-TrCP alterations in dopaminergic neurons with changed expression, modified protein quality control, and implications for PD pathogenesis.

SCF Complex Assembly and Mechanism

Structural Organization

The SCF (Skp1-Cullin1-F-box) ubiquitin ligase complex is a multisubunit E3 ligase that catalyzes polyubiquitination of specific substrates[@zheng2016]. β-TrCP serves as the substrate recognition subunit and is recruited to the core complex through its F-box motif. The assembly involves:

Skp1 (S-phase kinase-associated protein 1): Adaptor protein that bridges Cullin1 to F-box proteins
Cullin1: Scaffold protein that organizes the complex
Rbx1 (RING-box 1): E2 ubiquitin-conjugating enzyme recruiter
F-box protein (β-TrCP): Substrate recognition component

Substrate Recognition

β-TrCP specifically recognizes substrates containing a phosphorylated degron motif with the consensus sequence DSGxxS[@winston1999]. Recognition requires:

Phosphorylation of the degron: Substrate must be phosphorylated at specific serine/threonine residues by upstream kinases (e.g., IκB kinases, GSK3β, CK1)

Dimer formation: β-TrCP forms homodimers that recognize phosphodegrons

Ubiquitination: After binding, the SCF complex transfers ubiquitin to the substrate

The WD40 repeat domain forms a beta-propeller structure that creates a phosphodegron-binding pocket with high specificity for phosphorylated serine residues in the DSGxxS motif.

Role in NF-κB Signaling

IκBα Degradation

β-TrCP is essential for NF-κB signaling through regulation of IκBα degradation[@karin2000]. The pathway operates as follows:

Pro-inflammatory signals activate IKK (IκB kinase) complex

IKK phosphorylates IκBα at Ser32 and Ser36

Phosphorylated IκBα is recognized by β-TrCP via its phosphodegron

SCFβ-TrCP ubiquitinates IκBα, targeting it for proteasomal degradation

NF-κB (p65/p50) is released and translocates to the nucleus

Neuroinflammation in AD and PD

Dysregulated NF-κB signaling contributes to chronic neuroinflammation in neurodegenerative diseases[@choi2014]:

Alzheimer's disease: Amyloid-beta activates NF-κB in microglia, leading to pro-inflammatory cytokine production
Parkinson's disease: Neuroinflammation in substantia nigra involves NF-κB pathway dysregulation
Therapeutic targeting: β-TrCP modulators may normalize NF-κB signaling

Microglial Activation

β-TrCP modulates microglial activation states:

M1 (pro-inflammatory): Enhanced β-TrCP expression
M2 (anti-inflammatory): Reduced β-TrCP levels
Therapeutic targeting of β-TrCP may shift microglial polarization

Wnt/β-Catenin Signaling

β-Catenin Degradation

β-TrCP controls Wnt signaling by targeting β-catenin for degradation[@maniatis1999]. In the absence of Wnt ligand:

GSK3β phosphorylates β-catenin at multiple sites within its destruction complex

Phosphorylated β-catenin is recognized by β-TrCP

Ubiquitination targets β-catenin for proteasomal degradation

Low β-catenin levels prevent transcription of Wnt target genes

Synaptic Plasticity and Memory

Wnt signaling is crucial for synaptic plasticity and memory formation[@ma2008]. β-TrCP-mediated β-catenin degradation affects:

Dendritic spine morphology
Synaptic strength
Long-term potentiation (LTP)
Memory consolidation

Altered β-TrCP function may contribute to synaptic deficits in Alzheimer's disease.

Circadian Rhythm Regulation

PER1/2 Degradation

β-TrCP plays a key role in circadian rhythm by targeting clock proteins PER1 and PER2 for degradation[@song2019]. The circadian clock operates in a 24-hour cycle:

CLOCK/BMAL1 transcription factors activate period genes (PER1/2/3) and cryptochrome genes (CRY1/2)

PER/CRY proteins accumulate and form complexes that inhibit CLOCK/BMAL1

β-TrCP recognizes phosphorylated PER proteins

Ubiquitination leads to PER degradation, resetting the clock

Neurodegenerative Implications

Circadian disruption is increasingly recognized in neurodegenerative diseases:

Altered circadian patterns in AD and PD patients
Sleep disturbances precede clinical symptoms
β-TrCP dysfunction may contribute to circadian abnormalities

Role in Synaptic Function

Synaptic Plasticity

β-TrCP is involved in synaptic plasticity through regulation of multiple synaptic proteins[@latreille2009]:

AMPA receptor subunit turnover: β-TrCP targets GluA1 for degradation
Synaptic scaffold proteins: Regulation of PSD-95 levels
Presynaptic proteins: Modulation of synaptic vesicle proteins

Synaptic Pruning

During development, β-TrCP may participate in synaptic pruning[@suzuki2017]:

NF-κB signaling regulates microglial activation
Complement-mediated synapse elimination
Aberrant pruning in neurodegenerative diseases

Protein Quality Control in Neurodegeneration

UPS Dysfunction in AD

The ubiquitin-proteasome system (UPS) is impaired in Alzheimer's disease[@ravi2019]. β-TrCP alterations include:

Reduced expression in AD brains
Impaired substrate recognition
Accumulation of β-TrCP targets
Contribution to protein aggregate formation

Autophagy and Parkin

β-TrCP intersects with autophagy pathways relevant to Parkinson's disease[@liman2013]:

Regulation of mitophagy receptors
Interaction with parkin-mediated degradation
Influence on α-synuclein clearance

Tau Protein Degradation

β-TrCP is involved in tau turnover:

Phosphorylated tau can be recognized by β-TrCP
Impaired β-TrCP function leads to tau accumulation
May contribute to neurofibrillary tangle formation

Autophagy Regulation

β-TrCP regulates autophagy through multiple mechanisms:

Targeting autophagy inhibitors for degradation
Modulating mTOR pathway components
Controlling mitophagy receptors

Mutations and Genetic Associations

Cancer Mutations

Several cancer-associated mutations affect β-TrCP function[@shen2015]:

Missense mutations in the WD40 domain impair substrate recognition
Deletion mutations remove substrate-binding capacity
Frameshift mutations produce truncated proteins

Neurodegeneration Risk

While direct neurodegeneration-causing mutations in BTRC are rare:

Polymorphisms may influence disease risk
Altered expression contributes to pathogenesis
Gene-environment interactions may be important

Therapeutic Implications

Targeting SCFβ-TrCP

Modulating SCFβ-TrCP activity represents a therapeutic strategy[@kurosaki2022]:

Inhibitors: Block substrate recognition to stabilize target proteins
Inducers: Increase β-TrCP expression to enhance degradation
Selectivity: Achieve pathway-specific effects

Drug Development

Several approaches are being explored:

NF-κB inhibitors: For reducing neuroinflammation
Wnt pathway modulators: For synaptic protection
UPS enhancers: For improving protein clearance
β-TrCP agonists: To enhance degradation of pathological proteins
Proteasome enhancers: To improve overall protein clearance capacity

Clinical Relevance

β-TrCP modulators may have applications in:

Alzheimer's disease: Reducing amyloid and tau accumulation
Parkinson's disease: Enhancing α-synuclein clearance
Amyotrophic lateral sclerosis: Improving TDP-43 clearance
Frontotemporal dementia: Targeting tau and TDP-43 pathology

Challenges

Key challenges include:

Achieving brain penetration
Achieving pathway specificity
Balancing beneficial versus harmful effects on protein turnover

Expression and Regulation

Tissue Distribution

β-TrCP is widely expressed:

High expression: Brain, lung, kidney
Moderate expression: Liver, heart, muscle
Low expression: Peripheral blood cells

Brain Region Expression

Cortex: Neuronal and glial expression
Hippocampus: High in pyramidal neurons
Substantia nigra: Dopaminergic neurons
Cerebellum: Purkinje cells

Regulation Mechanisms

β-TrCP is regulated at multiple levels:

Transcriptional: Stress-responsive promoters
Post-translational: Auto-ubiquitination
Subcellular: Nuclear-cytoplasmic shuttling

References

[Dorvault et al., Beta-TrCP in NF-kB (2021)](https://doi.org/10.1016/j.cyto.2021.155431)

[Karin & Ben-Neriah, NF-kB regulation (2000)](https://doi.org/10.1146/annurev.immunol.18.1.621)

[Fuchs et al., beta-TrCP cellular functions (2004)](https://doi.org/10.1016/j.tcb.2004.09.003)

[Guardavaccaro & Pagano, SCF beta-TrCP (2006)](https://doi.org/10.1016/j.tcb.2006.08.005)

[Singh et al., Beta-TrCP in PD (2012)](https://doi.org/10.1016/j.neurobiolaging.2011.09.014)

[Ciani et al., beta-TrCP and neurodegeneration (2019)](https://doi.org/10.1007/s12035-018-1440-y)

[Tanaka et al., SCF beta-TrCP in AD (2018)](https://doi.org/10.1111/jnc.14463)

[Liu et al., beta-TrCP in aging (2020)](https://doi.org/10.1007/s11357-020-00226-7)

[Lu et al., beta-TrCP therapeutic target (2004)](https://doi.org/10.1016/j.drup.2004.08.001)

[Winston et al., SCF complex (2010)](https://doi.org/10.1124/mi.104.056317)

[Suzuki et al., beta-TrCP in cancer (2011)](https://doi.org/10.1349-7006.2011.01936.x)

[Winston et al., SCF beta-TrCP function (1999)](https://pubmed.ncbi.nlm.nih.gov/10531055/)

[Maniatis, ubiquitin ligase complex (1999)](https://pubmed.ncbi.nlm.nih.gov/10572187/)

[Latreille et al., beta-TrCP in neuronal development (2009)](https://pubmed.ncbi.nlm.nih.gov/19340752/)

[Ma et al., beta-catenin in synaptic plasticity (2008)](https://pubmed.ncbi.nlm.nih.gov/18559340/)

[Ravi et al., UPS in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/30528554/)

[Liman et al., Parkin and protein degradation (2013)](https://pubmed.ncbi.nlm.nih.gov/23516260/)

[Shen et al., beta-TrCP mutations (2015)](https://pubmed.ncbi.nlm.nih.gov/25803279/)

[Zheng et al., SCF structure (2016)](https://pubmed.ncbi.nlm.nih.gov/26789245/)

[Suzuki et al., F-box in synaptic pruning (2017)](https://pubmed.ncbi.nlm.nih.gov/28535778/)

[Choi et al., NF-kB in AD (2014)](https://pubmed.ncbi.nlm.nih.gov/24800774/)

[Song et al., circadian rhythm in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31158311/)

[Kurosaki et al., SCF complexes (2022)](https://pubmed.ncbi.nlm.nih.gov/35190804/)

Diagram: β-TrCP in NF-κB Signaling

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving BTRC Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

BTRC Gene

BTRC (Beta-Transducin Repeat Containing Protein)

Overview

BTRC (Beta-Transducin Repeat Containing Protein)

Overview

Gene Structure and Evolution

Protein Structure

Domain Architecture

Phosphodegron Recognition

Biological Functions

Substrate Diversity

Role in Alzheimer's Disease

Role in Parkinson's Disease

SCF Complex Assembly and Mechanism

Structural Organization

Substrate Recognition

Role in NF-κB Signaling

IκBα Degradation

Neuroinflammation in AD and PD

Microglial Activation

Wnt/β-Catenin Signaling

β-Catenin Degradation

Synaptic Plasticity and Memory

Circadian Rhythm Regulation

PER1/2 Degradation

Neurodegenerative Implications

Role in Synaptic Function

Synaptic Plasticity

Synaptic Pruning

Protein Quality Control in Neurodegeneration

UPS Dysfunction in AD

Autophagy and Parkin

Tau Protein Degradation

Autophagy Regulation

Mutations and Genetic Associations

Cancer Mutations

Neurodegeneration Risk

Therapeutic Implications

Targeting SCFβ-TrCP

Drug Development

Clinical Relevance

Challenges

Expression and Regulation

Tissue Distribution

Brain Region Expression

Regulation Mechanisms

See Also

References

Diagram: β-TrCP in NF-κB Signaling

Pathway Diagram